Tianda Pharmaceuticals 455.HK · HKD

Its shares trade on HKEX under the ticker 455.HK. It has been listed since 30 March 1992. In the fiscal year to 31 December 2024, it reported revenue of HK$329.9m and a net loss of HK$61.4m. At that date it held total assets of HK$765.0m and shareholders' equity of HK$505.8m.

Tianda Pharmaceuticals Ltd. operates as an investment holding company, which engages in the research and development, manufacture and sale of pharmaceutical, biotechnology and healthcare products. The company employs 820 full-time employees The main businesses of the Company include the research and development, production and sales of pharmaceutical, biotechnology and healthcare products. Its products include cardio-cerebrovascular drugs, paediatric drugs, anti-flu and respiratory system drugs, anti-infection drugs, medicines for drug addicts and other pharmaceutical products, as well as healthcare products under the Herb Valley series. The firm operates businesses in Hong Kong, China and Australia.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Wen Quan FangExecutive Chairman of the Board, Managing Director, since 2003HK$60,000
• Mr. Man Sang LuiExecutive Director, since 2013HK$72,000
• Mr. Tai On LoCompany Secretary
• Mr. Quanming FengNon-Executive Director
• Mr. Bo ShenNon-Executive DirectorHK$72,000
• Mr. Tao ZhongNon-Executive Director
• Mr. Sung Hong ChiuIndependent Non-Executive DirectorHK$72,000
• Mr. Yat Fai LamIndependent Non-Executive DirectorHK$72,000
• Dr. Yanfang XianIndependent Non-Executive Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.